The information published on this situated one 
they have only a divulgativo character, 
and they cannot replace the medical visit.

 

MENOPAUSE

Menopause and Therapy

Google

web

gyneconline

 

 

 


DOCUMENT ON THE HORMONAL REPLACEMENT THERAPY  
(shared from scientific associations AOGOI, AGUI, SIGO, SIGITE, GOERM)

 

 

The SUBSTITUTIVE HORMONAL THERAPY has the scope to replace hormones 
(ESTROGENIC - PROGESTERONE) that in menopause more they are not produced from the ovaie, with the objective to correct those problems caused from the hormonal deficiency.

SUBSTITUTIVE HORMONAL THERAPY

Start of the therapy

Duration of the therapy

Ways of somministrazione

Outlines of therapy

Absolute contraindications

Relative contraindications

Medical controls

Benefits

Start of the therapy:
the therapy would have to be begun to the decline of the ovarian function;
many effects of the estrogenica deficiency are more expresses in the first years of postmenopause.

Duration of the therapy:
The objective of the therapy is the prevention of pathologies that take part in the postmenopausal age.
It is thought that a useful life of therapy is of some years, but not beyond the 5 years.

Outlines of therapy: 

Sequenziale (Estrogenic + Progesterone) 
- cyclical 
- it continues

Only Estrogenic (in the women without uterus for pregressa hysterectomy).

Ways of somministrazione:  

Transdermic way (doily - gel)),

Oral way,

Vaginal way.

Absolute contraindications:

Strict epatopatie in existence, 

Thrombosis or niggle in existence, 

Adenocarcinoma of the endometrium, 

Endometrioide carcinoma of the ovaio, 

Carcinoma of the mammella.

Relative contraindications: 

Calculosis of the colecisti: in this case the transdermica way is indicated,

Ipertrigliceridemia: indicated the transdermica way,

Fibromi uterini: in presence of fibromi it is from advising one therapy with Estrogens to low doses

Medical controls:  

Gynecological and internistic control, 

Examinations of laboratory,  

Examination of the breast and Mammography, 

Pelvic echography (for evaluation of the uterus-ovarian morphology and in particular of the endometrial thickness), 

Bony Densitometry (M.O.C or Bony Mineralometria Computerized) in order to estimate the degree of bony mineralization and therefore to diagnose an eventual osteoporosis prematurely.

It goes independently remembered that in the woman in menopause these controls are however advises to you, from the therapy.

Benefits:
The Substitutive Hormonal Therapy involves the following benefits:
it reduces clearly disturbs climaterici,
it improves the trofismo and the elasticity of the skin,
ischemica cardiopathy reduces the cardiovascular risk (),
it prevents the osteoporosis, reducing the risk of fractures,
it improves the trofismo of the genitourinary apparatus. 


 


Related Links:

 

Pagina redatta a cura del Dott. Giovanni Zerlotin


top